Combined Screening With NIPT Delfia_Manual.

Combined Screening With NIPT Delfia (Manual)

Overview

Combined Screening With NIPT Delfia (Manual) is a comprehensive prenatal screening package that combines first-trimester biochemical screening (DELFIA technology) with Non-Invasive Prenatal Testing (NIPT). It assesses the baby's risk for common chromosomal abnormalities using a maternal blood sample, offering high screening accuracy without posing a risk to the pregnancy.

Test Includes

• NIPT (Cell-Free Fetal DNA Analysis)
• DELFIA First Trimester Screening Markers
  • Free β-hCG
  • PAPP-A
• Maternal clinical information assessment
• Combined risk calculation and interpretation

Why is this Test Done?

• Screens for common fetal chromosomal abnormalities.
• Provides early pregnancy risk assessment.
• Helps guide decisions regarding further diagnostic testing.
• Reduces unnecessary invasive procedures in low-risk pregnancies.

Conditions Screened

• Trisomy 21 (Down Syndrome)
• Trisomy 18 (Edwards Syndrome)
• Trisomy 13 (Patau Syndrome)
• Sex chromosome abnormalities (where included)
• First-trimester chromosomal risk assessment

Who Should Consider This Test?

• Pregnant women between 10–13+6 weeks of gestation.
• Women aged 35 years or older.
• History of chromosomal abnormalities in previous pregnancies.
• Positive or high-risk first-trimester screening results.
• Couples seeking advanced prenatal screening.

Sample Required

• Maternal Peripheral Blood

Preparation

• No fasting required.
• Inform your healthcare provider about:
  • Gestational age
  • IVF pregnancy (if applicable)
  • Multiple pregnancy
  • Previous transplant or blood transfusion
  • Maternal medical history

Turnaround Time

Approximately 7–14 working days (may vary depending on laboratory workflow).

Benefits

• Safe and non-invasive prenatal screening.
• High sensitivity and specificity for common trisomies.
• Early detection supports informed pregnancy management.
• Combines biochemical screening with advanced genetic analysis for enhanced risk assessment.

Important Note

This is a screening test, not a diagnostic test. A high-risk result should be confirmed with diagnostic procedures such as Chorionic Villus Sampling (CVS) or Amniocentesis, as recommended by your healthcare provider.

Book your Combined Screening With NIPT Delfia (Manual) test at Advanced BioCare Laboratories for accurate, reliable, and timely prenatal screening.